On an STI microbiology-and-window-period MCQ, the tempting mistake is to sort infections into “quick” and “slow” and attach one number to each. Instead, ask what the test detects, which site was sampled, and which clinical clock the question is testing. That distinction helps you interpret a negative result without over-reassuring a patient—or choosing the wrong follow-up step.
First name the clock
“Repeat testing” can mean different things. Label the purpose before you recall an interval:
| Clock | What it asks | Common board trap |
|---|---|---|
| After exposure | Could this test detect infection from a recent encounter now? | Treating an early negative as proof that infection was not acquired. |
| Test of cure | Has treatment cleared an established infection? | Confusing post-treatment testing with a diagnostic window. |
| Retesting for reinfection | Has infection occurred again after treatment? | Treating a 3-month retest as a universal STI window period. |
For example, during pregnancy, a chlamydia test of cure is recommended about 4 weeks after treatment. After chlamydia or gonorrhea, retesting at about 3 months is intended to identify repeat infection. Those are treatment follow-up decisions—not a claim that those infections always take weeks or months to become detectable.
Match the test to what it detects
For Chlamydia trachomatis and Neisseria gonorrhoeae, nucleic acid amplification tests (NAATs) are recommended for diagnosis. But a test only answers for the specimen collected. For urogenital testing in women, a vaginal swab is an optimal specimen; testing of rectal or pharyngeal sites depends on reported exposure and the clinical context. A negative urine or vaginal result does not answer whether infection is present at an untested site.
Do not memorize a universal day-after-sex cutoff for every chlamydia or gonorrhea test. The guidance specifies diagnostic tests and specimen sites, but not one postexposure day that guarantees every assay will detect every infection. A very early negative may not exclude infection from that encounter. If symptoms are present, evaluate the patient now rather than postponing assessment until an assumed window expires.
Syphilis questions test a different distinction: blood tests detect antibodies, which may not yet be detectable in very early infection. But when a patient had sexual contact with someone diagnosed with primary, secondary, or early latent syphilis less than 90 days before that person’s diagnosis, CDC guidance recommends presumptive treatment even if the exposed patient’s serology is negative. In that stem, the known exposure changes the action; repeating a negative result is not the whole answer.
HIV test windows depend on the type of assay. CDC gives these usual ranges:
| HIV test | Usual window after exposure |
|---|---|
| Nucleic acid test (NAT) | 10–33 days |
| Laboratory antigen/antibody test, blood from a vein | 18–45 days |
| Rapid antigen/antibody test, finger stick | 18–90 days |
| Antibody test | 23–90 days |
So “HIV testing is negative” is incomplete information in a window-period question. Identify the test. A negative result obtained before that test’s window has elapsed does not rule out infection from the recent exposure; later exposures also affect when follow-up testing is needed.
Turn a negative result into a plan
Consider a board stem in which a patient presents 48 hours after sex without a condom and has negative urine chlamydia/gonorrhea and HIV tests. The defensible interpretation is not “no STI.” Ask which anatomic sites were tested and whether symptoms are present; the result may not address untested sites or infection acquired in the recent encounter. For HIV, identify the assay and plan follow-up using its window period.
If the exposure could meet criteria for HIV postexposure prophylaxis (nPEP), assess urgently: nPEP should begin as soon as possible and no later than 72 hours after exposure when indicated. Do not wait for pending laboratory results before starting an indicated first dose. If the patient takes nPEP, use its specific follow-up testing guidance rather than applying the routine, untreated window-period table.
A six-minute retrieval exercise
Close your notes. For each prompt, write one sentence stating what the result does—and does not—tell you, then one sentence naming the next decision:
- A urine chlamydia/gonorrhea NAAT is negative the day after exposure. Which site was tested, and what remains unresolved?
- A patient had contact less than 90 days before the source was diagnosed with early syphilis; the patient’s serology is negative. What does the exposure history change?
- An HIV test is negative two days after a possible exposure. Which test type determines the usual window, and what time-sensitive assessment comes before waiting for follow-up testing?
Check your answers against the guidance, then label each missed point: clock error, assay error, site error, or priority error. The label matters: rereading a paragraph will not fix a mistaken assumption that a urine sample tests every exposed site or that a 3-month retest is a diagnostic window. Retrieve the three answers again the next day without looking.
Practical takeaways
- Name the clock: postexposure detection, test of cure, or retesting for reinfection.
- For chlamydia and gonorrhea, match the NAAT specimen to the exposed site; do not invent a universal postexposure cutoff.
- For HIV, identify the assay before interpreting its window period.
- A negative early syphilis serology does not override the presumptive-treatment recommendation for a qualifying recent contact with early syphilis.
- If HIV nPEP may be indicated, act within the 72-hour window; do not wait for test results.
